Al-Lamki Rafia S, Wang Jun, Thiru Sathia, Pritchard Nicholas R, Bradley J Andrew, Pober Jordan S, Bradley John R
Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom.
Am J Pathol. 2003 Aug;163(2):401-11. doi: 10.1016/S0002-9440(10)63670-X.
We have previously reported the pattern of cellular expression of tumor necrosis factor receptors (TNFR) in human kidney and their altered expression in transplant rejection. We have extended our studies to examine the expression of Silencer of Death Domains (SODD), a protein that binds to the cytoplasmic portion of TNFR1 to inhibit signaling in the absence of ligand. In normal human kidney SODD is expressed in glomerular endothelial cells where it colocalizes with TNFR1. During acute rejection both SODD and TNFR1 are lost from glomeruli, but we found strong expression of SODD on the luminal surface of tubular epithelial cells. This occurs in the absence of detectable TNFR1 expression, suggesting that SODD could interact with other proteins at these sites. Several other members of the TNF superfamily, including Fas and death receptors (DR)-3, -4, and -5, also contain intracellular death domains, but SODD only interacts with the death domain of DR3. We therefore studied the expression of DR3 in human kidney, and report that this death receptor is up-regulated in renal tubular epithelial cells and endothelial cells of some interlobular arteries, in parallel with SODD, during acute transplant rejection. In less severe rejection episodes, DR3 and SODD were more focally induced, generally at sites of mononuclear cell infiltrates. In ischemic allografts, eg, with acute tubular necrosis but no cellular rejection, DR3 was induced on tubular epithelial cells and on glomerular endothelial cells. These data confirm that TNF receptor family members are expressed in a regulated manner during renal transplant rejection, and identify DR3 as a potential inducible mediator of tubular inflammation and injury.
我们之前曾报道过肿瘤坏死因子受体(TNFR)在人肾脏中的细胞表达模式及其在移植排斥反应中的表达变化。我们进一步扩展研究,以检测死亡结构域沉默蛋白(SODD)的表达,该蛋白可与TNFR1的胞质部分结合,在无配体情况下抑制信号传导。在正常人类肾脏中,SODD在肾小球内皮细胞中表达,并与TNFR1共定位。在急性排斥反应期间,肾小球中SODD和TNFR1均消失,但我们发现肾小管上皮细胞腔面有强烈的SODD表达。这发生在未检测到TNFR1表达的情况下,提示SODD可能在这些位点与其他蛋白相互作用。TNF超家族的其他几个成员,包括Fas和死亡受体(DR)-3、-4和-5,也含有细胞内死亡结构域,但SODD仅与DR3的死亡结构域相互作用。因此,我们研究了DR3在人肾脏中的表达,并报告在急性移植排斥反应期间,该死亡受体在肾小管上皮细胞和一些小叶间动脉的内皮细胞中与SODD平行上调。在较轻的排斥反应中,DR3和SODD的诱导更具局灶性,通常在单核细胞浸润部位。在缺血性同种异体肾移植中,例如伴有急性肾小管坏死但无细胞排斥反应时,DR3在肾小管上皮细胞和肾小球内皮细胞上被诱导表达。这些数据证实TNF受体家族成员在肾移植排斥反应期间以一种受调控的方式表达,并确定DR3为肾小管炎症和损伤的潜在诱导介质。